Access cutting-edge narcolepsy type 1 treatment through this clinical trial at a research site in Columbia. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Columbia location
Preparing your pre-screening questions…
Access narcolepsy type 1 specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related narcolepsy type 1 treatment provided free
Check if you qualify for this narcolepsy type 1 clinical trial in Columbia, SC
No-Cost Study Care
Local to Columbia
Convenient for SC residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Narcolepsy Type 1 (NT1) and Narcolepsy Type 2 (NT2) are rare conditions that make people feel very sleepy during the day (often referred to as excessive daytime sleepiness \[EDS\]). People living with these conditions might find it hard to stay alert and pay attention when they are at school, working, driving, or performing other daily activities. While all conditions result in feeling sleepy, there are some differences in other common symptoms: * NT1: People with NT1 often feel very tired during the day and experience cataplexy. Cataplexy is a sudden loss of muscle strength, which can cause someone to collapse or lose control of their muscles for a short time. This is often triggered by strong emotions, such as laughter or surprise. They may also have trouble sleeping well at night. * NT2: People with NT2 feel sleepy during the day, just like NT1, but they do not have cataplexy. Orexin is a protein in the brain that helps coordinate a system that plays an important role in helping people to stay awake during the daytime. Cleminorexton is designed to mimic the action of orexin. The purpose of this study is to see how safe and tolerable cleminorexton is in NT1 and NT2 and learn about what the drug does to the body. Another goal of the study is to see if cleminorexton can help people with NT1 and NT2 feel less sleepy and make other symptoms better.
Sponsor: Centessa Pharmaceuticals (UK) Limited
Yes, this clinical trial (NCT07598708) has an active research site in Columbia, SC that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for narcolepsy type 1 treatment options in Columbia, SC, this clinical trial (NCT07598708) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Columbia research site is actively enrolling participants for this clinical trial. You'll receive care from experienced narcolepsy type 1 specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all narcolepsy type 1 clinical trials near you to find additional studies recruiting in your area.
See all pulmonary embolism clinical trials recruiting in Columbia — not just this study.
Browse Pulmonary Embolism Trials in Columbia →